RATIONALE AND OBJECTIVES: To investigate factors influencing the success and complication rate of percutaneous transhepatic biliary drainage (PTBD).

MATERIALS AND METHODS: PTBD procedures between 2017 and 2022 were enrolled retrospectively. Success rate, complications, and technical considerations were compared using Mann-Whitney U-, X2-, and Fishers exact tests. The influence of the study center's experience (training-effect) on success and complication rates was assessed by linear regression categorized by year.

RESULTS: In 398 patients, 499 PTBD procedures (337 men; mean age 66.2 +/- 12.5 years) were carried out, with a success rate of 83.2% (415/499). PTBD in dilated bile ducts was more successful than in non-dilated bile ducts (90.0%; 316/340 vs. 68.6%; 109/159; p < 0.001), with e.g. lower radiation doses (2787.52 +/- 4012.72 cGy*cm2 vs. 4679.25 +/- 4663.55 cGy*cm2; p < 0.001), and shorter total procedure time (33.42 +/- 24.03 min vs. 41.09 +/- 27.21 min; p < 0.001). Complications occurred in 34/499 (6.8%) procedures (major complications n = 25/34) with no significant difference in bile duct width. Right-sided PTBD revealed more complications (9.0%; 30/332 vs. 2.4%; 4/166; p = 0.006) and higher radiation doses (3679.47 +/- 4571.71 cGy*cm2 vs. 2819.01 +/- 3724.92 cGy*cm2; p = 0.001) than left-sided approaches. Linear regression showed a significant continuous increase in the technical success rate of 3.0% per year (2017-2022; 72.5%; 78.5%; 82.2%; 85.0%; 89.0%; 87.5%; p = 0.005), while the overall complication rate remained unaffected (p = 0.364).

CONCLUSION: Medical centers adopting PTBD procedures can potentially increase their success rate significantly within a short period of time. PTBD is a safe procedure, with left-sided approaches showing lower complication rates and radiation exposure, underscoring their often-underestimated advantages in clinical practice.